Long-Term Effects of the Oral Adsorbent,AST-120,in Patients with Chronic Renal Failure

Abstract

The oral adsorbent AST-120 has been widely used in Japan to delay the initiation of dialysis therapy in patients with chronic renal failure. This study evaluated the long-term effects of AST-120 in patients with chronic renal failure who had not previously undergone dialysis. One hundred out-patients were prospectively enrolled and prescribed 6 g/day oral AST-120 for ≥ 1 year. The clinical effectiveness of AST-120 was evaluated by comparing changes in the slope of the reciprocal serum creatinine-time plot (1/sCr slope) before and after AST-120 administration. The 1/sCr slope improved significantly after ≥ 1 year of AST-120 treatment and greatest improvement was observed in patients with the longest AST-120 administration period (> 30 months). The results suggest that long-term treatment with AST-120 may be beneficial for chronic renal failure patients in the pre-dialysis stage.

Keywords

Oral adsorbent AST-120 Chronic renal failure Reciprocal serum creatinine Long-term use

References

Patients' Registration Committee: An overview of regular dialysis treatment in Japan (as of 31 December 2005). Annual Report of the Japanese Society for Dialysis Therapy. Tokyo: Japanese Society for Dialysis Therapy, 2006.

Zandi-Nejad

Brenner

: Strategies to retard the progression of chronic kidney disease. Med Clin N Am 2005; 89: 489–509.

Kobayashi

Maeda

Horikoshi

: Effects of oral adsorbent AST-120 (Kremezin®) on renal function and glomerular injury in early-stage renal failure subtotal nephrectomized rats. Nephron 2002; 91: 480–485.

Niwa

Ise

: Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis. J Lab Clin Med 1994; 124: 96–104.

Owada

Nakao

Koike

: Effect of oral adsorbent AST-120 on the progression of chronic renal failure: A randomized controlled study. Kidney Int 1997; 52 (suppl 63): S188–S190.

Motojima

Hosokawa

Yamato

: Uremic toxins induce proximal tubular injury via organic anion transporter 1-mediated uptake. Br J Pharmacol 2002; 135: 555–563.

Shoji

Wada

Inoue

: Prospective randomized study evaluating the efficacy of the spherical adsorptive carbon AST-120 in chronic kidney disease patients with moderate decrease in renal function. Nephron Clin Pract 2007; 105: c99–c107.

Takahashi

Kawaguchi

Suzuki

: Therapeutic effects of long-term administration of an oral adsorbent in patients with chronic renal failure: Two-year study. Int J Urol 2005; 12: 1–5.

Sanaka

Akizawa

Koide

: Clinical analysis of retrospective responding patients administrated with oral adsorbent in chronic renal failure secondary to chronic glomerulonephritis. Ther Apher Dial 2003; 7: 269–278.

10.

Sanaka

Fujimoto

Niwayama

: Effect of combined treatment of oral sorbent with protein-restricted diet on change of reciprocal creatinine slope in patients with CRF. Am J Kidney Dis 2003; 41 (suppl 1): S35–S37.

11.

Goto

Moridera

Baba

: Effects of oral adsorbent Kremezin administration on the deterioration of renal failure in diabetic patients with chronic renal failure – A report of the Hanshin Diabetic Nephropathy Research Group. J Japan Diab Soc 2001; 44: 377–385 [in Japanese].